Cue Health CEO on new Covid-19 diagnostic test
Health-care technology company Cue Health received emergency use authorization from the FDA for its rapid point-of-care test for coronavirus. Ayub Khattak, co-founder and CEO of Cue Health, joins “Squawk Box” to discuss.
More News
Cue Coverage
Google’s provider of at-home Covid-19 tests is now a $3 billion company traded on Nasdaq
Read More >>
Covid Test Startup Cue Health in Talks for $2 Billion-Plus Valuation
Read More >>
Cue Health raises $100 million to speed development of rapid, portable COVID-19 diagnostics
Read More >>
Cue Health awarded $13 million government contract to develop portable, point-of-care COVID-19 test
Read More >>
Ready Responders land $48M to administer COVID-19 tests at home
Read More >>
View More Portfolio Company News
Select Another Portfolio Company